Premium Nahrungsergänzungsmittel | artgerecht

Inflammation Screening – Markers, Process & Significance

Inflammation screening is a diagnostic blood test used to detect silent or chronic inflammatory processes in the body through specific biomarkers.

Regular tips about health Regular tips about health

Things worth knowing about "Inflammation Screening"

Inflammation screening is a diagnostic blood test used to detect silent or chronic inflammatory processes in the body through specific biomarkers.

What Is Inflammation Screening?

Inflammation screening is a targeted laboratory examination in which specific inflammatory markers in the blood are measured to detect acute or chronic inflammatory processes at an early stage. Many inflammations initially occur without noticeable symptoms – this is referred to as silent inflammation. Over time, however, these low-grade inflammatory processes can contribute to serious conditions such as cardiovascular disease, type 2 diabetes, autoimmune disorders, or chronic pain syndromes.

Inflammation screening is used both in preventive medicine and as a diagnostic tool, providing important information about a patient's overall state of health.

Which Markers Are Tested?

A comprehensive inflammation screening panel typically includes several laboratory parameters that together provide a detailed picture of inflammatory activity in the body:

CRP (C-reactive protein): The primary general marker of inflammation. Elevated CRP levels suggest an acute or chronic inflammatory response.
hsCRP (high-sensitivity CRP): A more sensitive measurement of CRP that can detect even low levels of inflammation and is an important marker for cardiovascular risk.
Erythrocyte sedimentation rate (ESR): A classic, non-specific inflammatory marker measuring how quickly red blood cells settle.
Leukocytes (white blood cells): Elevated white blood cell counts may indicate infection or inflammation.
Ferritin: An iron-storage protein that also acts as an acute-phase reactant, rising during inflammatory conditions.
Homocysteine: An amino acid derivative whose elevated levels are associated with chronic inflammation and cardiovascular disease.
Interleukin-6 (IL-6): An inflammatory signaling molecule (cytokine) that may be elevated in acute and chronic inflammation.
TNF-alpha (tumor necrosis factor-alpha): Another key cytokine involved in inflammatory processes.

When Is Inflammation Screening Recommended?

Inflammation screening may be indicated in several situations:

In cases of unexplained symptoms such as persistent fatigue, exhaustion, or diffuse pain
As part of preventive healthcare and routine health check-ups
In patients with known risk factors for cardiovascular disease
For monitoring known inflammatory conditions (e.g., rheumatoid arthritis, Crohn's disease)
When an autoimmune disease is suspected
As part of a comprehensive general health assessment

How Is the Test Performed?

Inflammation screening is typically carried out through a straightforward blood draw, usually in the morning on an empty stomach. The blood sample is analyzed in a specialist laboratory, and results are generally available within 24 to 48 hours. A physician interprets the results in the context of the patient's medical history and other clinical findings.

Interpreting the Results

Elevated inflammatory markers alone do not provide a definitive diagnosis – they indicate that further diagnostic steps may be necessary. The treating physician will assess the values as part of the overall clinical picture:

Acute elevations may point to infections, injuries, or acute illness.
Persistently mildly elevated values suggest chronic low-grade inflammation that may not yet be causing noticeable symptoms.
Normal values do not entirely rule out inflammation but can generally be considered reassuring.

Therapeutic Implications

Depending on the findings, various measures may be recommended. For chronically elevated inflammatory markers, physicians commonly advise:

Dietary modifications (e.g., an anti-inflammatory diet rich in omega-3 fatty acids, antioxidants, and dietary fiber)
Regular physical activity
Stress reduction and adequate sleep
Avoidance of smoking and excessive alcohol consumption
Targeted pharmacological or naturopathic treatment, depending on the underlying cause

References

Ridker PM. - From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection. Circulation Research, 2016.
World Health Organization (WHO): Noncommunicable diseases and their risk factors. Available at: https://www.who.int/health-topics/noncommunicable-diseases (accessed 2024).
Libby P, Ridker PM, Maseri A. - Inflammation and Atherosclerosis. Circulation, 2002;105(9):1135-1143.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.